• NEWS

    NEWS

    THE LATEST NEWS, DEVELOPMENTS AND ANNOUNCEMENTS AS THEY HAPPEN

    more
  • EVENTS

    EVENTS

    CONFERENCES, TRADE SHOWS, LIVE WEBCASTS, NEW LAUNCHES, SEMINARS AND TRAINING EVENTS

    more
  • COMPANIES

    COMPANIES

    PARTNERS, SOLUTIONS & SERVICE PROVIDERS, SUPPLIERS AND INDUSTRY ORGANIZATIONS

    more
  • RESOURCES

    RESOURCES

    WHITEPAPERS, MARKET REPORTS, RESEARCH, ON-DEMAND WEBINARS, VIDEOS AND INFOGRAPHICS

    more

NEWS

   

    home.aspx
  • Imara raises $63m for sickle cell drug trials

    US biotech Imara has raised $63 million for clinical development of its sickle cell disease drug, which is in mid-stage development. Imara attracted investors including Arix Bioscience, which has inve...


    READ MORE
    https://pharmaphorum.com/news/imara-raises-63m-for-sickle-cell-drug-trials/2809
  • Allergy Therapeutics suffers phase 3 birch allergy jab trial failure

    UK-based Allergy Therapeutics has suffered a setback after phase 3 results from the B301 trial of its latest birch allergy product failed to reduce symptoms. The biotech already markets jabs for tree ...


    READ MORE
    https://pharmaphorum.com/news/allergy-therapeutics-suffers-phase-3-birch-allergy-jab-trial-failure/2810
  • Apple Watch shows early promise in AFib diagnosis

    A large-scale study has provided some evidence that the Apple Watch could be used to detect atrial fibrillation (AFib) and provide a potentially life-saving early warning for the condition – alt...


    READ MORE
    https://pharmaphorum.com/news/apple-watch-shows-early-promise-in-afib-diagnosis/2811
  • Karuna raises $68m to develop neurology drug KarXT

    Karuna Therapeutics has raised $68 million to further develop its neurology drug KarXT, which is in phase 2 clinical development for acute psychosis in patients with schizophrenia. Formerly known as K...


    READ MORE
    https://pharmaphorum.com/news/karuna-raises-68m-to-develop-neurology-drug-karxt/2812
  • Aerpio Asset AKB-9778 Fails to Hit Endpoints in Phase IIb Diabetic Retinopathy Trial

    Shares of Aerpio Therapeutics have sunk more than 70 percent this morning after the Ohio-based company announced its lead drug candidate AKB-9778 failed to meet endpoints in a mid-stage trial for pati...


    READ MORE
    https://www.biospace.com/article/aerpio-asset-akb-9778-fails-to-hit-endpoints-in-phase-iib-diabetic-retinopathy-trial/2813
  • Celgene gets US patent let-off ahead of BMS merger

    Shares in Celgene ticked up yesterday after a let-off in a US court case challenging the patents on its multi-billion dollar cancer drug Revlimid, a decision that could ease shareholder tensions ahead...


    READ MORE
    https://pharmaphorum.com/news/celgene-gets-us-patent-let-off-ahead-of-bms-merger/2802
  • Researchers Use Pfizer’s Anti-Smoking Drug Chantix to Control Neurons

    Researchers with the Howard Hughes Medical Institute have conducted research using Pfizer’s anti-smoking drug Chantix to control neurons. The research has broad potential for targeted treatments...


    READ MORE
    https://www.biospace.com/article/researchers-use-pfizer-s-anti-smoking-drug-chantix-to-control-neurons-/2803
  • New Theranos Documentary Hits the Silver Screens, Then HBO

    Elizabeth Holmes, the founder of the now-failed Theranos, has become a subject of fascination for many people. Her ability to secure billions of dollars for her company without showing any supporting ...


    READ MORE
    https://www.biospace.com/article/new-theranos-documentary-hits-the-silver-screens-then-hbo/2804
  • California jury awards $29 million to woman with cancer who used J&J talc

    A California jury on Wednesday awarded $29 million to a woman who said that asbestos in Johnson & Johnson's talcum-powder-based products caused her cancer. The verdict, in California Superior ...


    READ MORE
    https://health.economictimes.indiatimes.com/news/pharma/california-jury-awards-29-million-to-woman-with-cancer-who-used-jj-talc/684047312794

EVENTS

Conferences

15th International Conference and Exhibition on  Nanomedicine and Pharmaceutical Nanotechnology

15TH INTERNATIONAL CONFERENCE AND EXHIBITION ON NANOMEDICINE AND PHARMACEUTICAL NANOTECHNOLOGY

March 18-19, 2019
15th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Nanotechnology and Nanomedicine. It also...

SUPERBUGS & SUPERDRUGS 2019

SUPERBUGS & SUPERDRUGS 2019

March 18-19, 2019
Inspiring the global commitment required to tackle multidrug-resistance among bacteria populations, as the global threat of antimicrobial resistance continues to grow. This year’s event will gather leaders from pharmaceutical companies, academia, and the wider scientific community together wit...

DRUG DISCOVERY CHEMISTRY

DRUG DISCOVERY CHEMISTRY

March 18-19, 2019
The drug discovery field is undergoing dramatic change. There is currently a reduced output of new medicines due to challenges in R&D, pricing pressures and regulations. While these challenges are slowing progress, demand for new, more effective medicines is steadily growing. However, new techno...

16th World Hematology Congress

16TH WORLD HEMATOLOGY CONGRESS

March 18-19, 2019
After the productive venture of series of hematology conferences around the globe ConferenceSeries llc Ltd is overwhelmed to welcome all the participants to CME Accrediated “16th World Hematology Congress” will be held on March 18-19, 2019 at Rome, Italy. The CME Accredited conference is...

International Conference on Diabetes and Cholesterol Metabolism

INTERNATIONAL CONFERENCE ON DIABETES AND CHOLESTEROL METABOLISM

March 14-15, 2019
Metabolic Diseases 2019 Highlights of the theme "Focus on Current Investigations, Treatment and Preventive Strategies for Diabetes & Metabolic Diseases" Which accentuation on the most recent advancements in aversion and treatment of different metabolic illnesses which might be because ...

26th International Molecular Medicine Tri-Conference

26TH INTERNATIONAL MOLECULAR MEDICINE TRI-CONFERENCE

March 10-15, 2019
Spanning five days, the 2019 Tri-Conference includes compelling talks, including case studies and joint partner presentations, will feature over 500 of your fellow industry and academic colleagues discussing themes of cancer research, big data, molecular diagnostics, precision medicine, rare disease...

25th World Congress on Dentistry and Oral Health

25TH WORLD CONGRESS ON DENTISTRY AND ORAL HEALTH

March 14-15, 2019
Dentistry Congress-2019 includes international attendee workshops, lectures, and symposia, including a designated registration area, a refreshment break, and gala lunch.  Dentists can join the Conference Series as an international member to receive discounts on registration. So come and join le...

12th World Congress on Virology and Infectious Diseases

12TH WORLD CONGRESS ON VIROLOGY AND INFECTIOUS DISEASES

March 13-14, 2019
This is the best opportunity to reach the largest cluster of participants from all over the world and it’s the best platform to develop new partnership and collaborations with pharmaceutical industries and healthcare industries. Excellent scientific platform for members from around the world f...

 

Webinars

MAR 18, 2019 | 10.00 AM
UNDERSTANDING THE PROPENSITY OF SEQUENCE VARIANTS DURING CELL LINE AND CULTURE PROCESS DEVELOPMENT
Currently an Associate Research Fellow, Lisa is a group leader in the Mass Spectrometry and Biophysical Characterization group at Pfizer in Andover, MA.  Lisa received a Bachelor of Science degree in biology from Union College in Schenectady NY and a Masters in Teaching from Boston Un...
MAR 19, 2019 | 10.00 AM
MOVING FROM CHALLENGES OF HIGH CONCENTRATION PROTEIN FORMULATIONS DEVELOPMENT TO MEET THE NEEDS OF HIGH POTENT BISPECIFICS
Monoclonal antibodies (mAbs) have significantly contributed to the treatment of oncological and immunological disorders over the last two decades. Next advancement in this line is the introduction of bispecific antibodies – molecules which can bind to two different receptors at the s...
MAR 19, 2019 | 1:00 PM
EMR: PREVENTING INACCURATE RECORDS
With the adoption of electronic medical records, decades worth of documentation and best retention practices based on maintenance of paper records has been rendered moot. For all the time, money and effort, EMR systems were not prepared or designed for production to other providers or thir...
MAR 19, 2019 | 8.30
THE NEXT GENERATION IN LIGHT SCATTERING FOR THE CHARACTERIZATION OF MACROMOLECULES AND NANOPARTICLES
Throughout this webinar, you will be hearing from a variety of Scientists from Wyatt Technology who will help explain some of the key advancements and improvements made in light scattering that we believe will provide future customers with state-of-the-art capabilities and unique benefits....
MAR 20, 2019 | 1:00 pm
SOLVING PATIENT MATCHING WITH THE NEW GOLD-STANDARD IN EMPI TECHNOLOGY
Hear how Axia Women’s Health, the largest integrated OB/GYN healthcare provider in the U.S., solved its patient matching challenges and dramatically reduced its duplicate records by deploying a cloud-based master patient index (MPI) solution in six weeks that uses the new gold-standa...
MAR 21, 2019 | 11.00 AM
OVERCOMING CLINICAL SUPPLY CHAIN CHALLENGES IN INVESTIGATOR-INITIATED STUDIES
Investigator-initiated studies help address important clinical questions, often without the bias of industry sponsorship. As these trials grow in size and complexity, investigators must be able to anticipate and address supply chain management problems. Some challenges they might face are ...

HOW TO IMPLEMENT NIR SPECTROSCOPY INTO THE PHARMACEUTICAL PROCESSES
This pharma webinar examines the technique of Near Infrared spectroscopy, and how it can be used in pharmaceutical research and development. Potential uses of this excellent PAT tool include identifying raw materials, process control testing and the examination of a final product. We also ...
PRACTICAL APPLICATION OF RMM IN PHARMACEUTICAL MANUFACTURING
The application of Rapid Microbiological Methods (RMM) is a topic that has gained interest over the past few years as pharmaceutical manufacturers investigate and look to gain improved efficiencies across all areas of their businesses – including the microbiology laboratory. This pharma w...
BIOPHARMA DEAL MAKING: LESSONS LEARNT FROM CASS BUSINESS SCHOOL’S STUDY OF STRATEGIC DEALS AND CORPORATE PORTFOLIO MANAGEMENT
Extensive prior studies have shown strong positive effects for targets and negative effects for acquirers but, they have focused on measuring value creation from individual deals, not a firm’s overall programs of activity and performance over longer time periods. This far reaching study an...
PRINCIPLES OF DIFFERENTIAL SCANNING CALORIMETRY (DSC) – THE MOST USED THERMAL ANALYSIS TECHNIQUE IN PHARMACEUTICALS
Differential scanning calorimetry (DSC) is the most frequently used thermal analysis technique alongside TGA, TMA and DMA. DSC is used to measure enthalpy changes due to changes in the physical and chemical properties of a material as a function of temperature or time. The method allows yo...
DIGITAL BEST PRACTICES FOR ACCELERATING DRUG DEVELOPMENT
Watch this on-demand webinar to hear from Robert Albert, Collaboration Lead at AstraZeneca, and Ellen Reilly, VP of Life Sciences at DocuSign, on the digital future of pharmaceuticals and the best practices for investing and adopting eSignature solutions to reduce development cycle time an...
WEBINAR - THE 7 DEADLY SINS OF PHARMA JOB APPLICATIONS
For the last 10 years, here at GetReskilled, we have been helping people from a wide range of backgrounds make mid-career changes into well-paid jobs and careers into the pharmaceutical and medical device manufacturing industries. With a decade of experience in the industry we’ve come to l...

RESOURCES

Perhaps unsurprisingly, one of the major world events that happened in 2016 was the UK referendum in June 2016 on whether to leave the EU. In the lead up to the vote, we published a head to head piece...

This year was a big year for Clinical Pharmacist, which started with its relaunch in January as a peer-reviewed journal and it being sent to all members of the Royal Pharmaceutical Society as part of ...

On 7 December 2016 the Competition and Markets Authority (“CMA”) took an infringement decision, resulting in the fining of pharmaceutical company Pfizer and distributor Flynn Pharma. The companies wer...

Two years ago, the leading German pharmaceutical company, Boehringer Ingelheim, applied to Slovak authorities for its new anti-diabetes drug, Synjardy, to be covered by health insurance. Drug manufac...

Herbert Smith Freehills (HSF) and Latham & Watkins won lead roles on Baxter International's acquisition of Claris Injectables for $625m, in a bid by Baxter to expand its portfolio of essential generic...

For FDA professionals focused on drug quality and safety, the rapid increase in imported drugs from nations where we devote limited inspection resources is of great concern. One way to address this co...

We all know someone who has been given the diagnosis of cancer. It is definitely life-changing. The first time I was effected by the diagnosis was when my father received it. I didn’t think to ask him...

Industry experts say the Obama administration's decision to lift a ban on importing Cuban pharmaceuticals and collaborating with the nation's researchers could bring the nation's cheaper, reputable me...

Digital health tech is moving beyond the consumer market. Research from Frost & Sullivan shows that the healthcare wearables device market could more than triple to $18.9 billion in 2020 from $5.1 bil...